Lamivudine/telbivudine-associated neuromyopathy: Neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion

Journal of Clinical Pathology

Volumn 67, Issue 11, 2014, Pages 999-1005

  Xu, Hongliang ^a   Wang, Zhaoxia ^a   Zheng, Lemin ^b   Zhang, Wei ^a   Lv, He ^a   Jin, Suqin ^a   Yuan, Yun ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Peking University Health Science Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; GENOMIC DNA; LAMIVUDINE; MITOCHONDRIAL DNA; TELBIVUDINE; ANTIVIRUS AGENT; THYMIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; LIMB WEAKNESS; MALE; MICROSCOPY; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL TOXICITY; MITOCHONDRION; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; NERVE BIOPSY; NERVE FIBER DEGENERATION; NEUROMUSCULAR DISEASE; NEUROPATHY; REAL TIME POLYMERASE CHAIN REACTION; SURAL NERVE; ANALOGS AND DERIVATIVES; BIOPSY; CHEMICALLY INDUCED; DRUG EFFECTS; HEPATITIS B; METABOLISM; MIDDLE AGED; MUSCLE DISEASE; MUSCLE MITOCHONDRION; PATHOLOGY; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SKELETAL MUSCLE; ULTRASTRUCTURE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BIOPSY; DNA, MITOCHONDRIAL; FEMALE; HEPATITIS B; HUMANS; LAMIVUDINE; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUSCULAR DISEASES; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; THYMIDINE; YOUNG ADULT;

EID: 84908371069     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-202069     Document Type: Article

References (25)

1. Harkisoen S, Arends JE, van Erpecum KJ, et al. Hepatitis b viral load and risk of hbv-related liver disease: From east to west? Ann Hepatol 2012;11:164-71.
2. Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis b. Hepatology 2009;49:S185-95.
3. Fleischer RD, Lok AS. Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis b. J Hepatol 2009;51:787-91.
4. Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis b. N Engl J Med 2007;357:2576-88.
5. Liaw YF, Gane E, Leung N, et al. 2-year globe trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis b. Gastroenterology 2009; 136:486-95.
6. Lee H, Hanes J, Johnson KA. Toxicity of nucleoside analogues used to treat aids and the selectivity of the mitochondrial DNA polymerase. Biochemistry 2003;42:14711-19.
7. Chen CH, Cheng YC. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J Biol Chem 1989;264:11934-7.
8. Vidal F, Domingo JC, Guallar J, et al. In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells. Antimicrob Agents Chemother 2006;50:3824-32.
9. Seok JI, Lee DK, Lee CH, et al. Long-term therapy with clevudine for chronic hepatitis b can be associated with myopathy characterized by depletion of mitochondrial DNA. Hepatology 2009;49:2080-6.
10. Gilkerson RW, Margineantu DH, Capaldi RA, et al. Mitochondrial DNA depletion causes morphological changes in the mitochondrial reticulum of cultured human cells. FEBS Lett 2000;474:1-4.
11. Divi RL, Haverkos KJ, Humsi JA, et al. Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to zidovudine. Environ Mol Mutagen 2007;48:179-89.
12. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 2007;8:870-9.
13. Chan DC. Mitochondrial dynamics in disease. N Engl J Med 2007;356:1707-9.
14. Dimmock D, Tang LY, Schmitt ES, et al. Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem 2010;56:1119-27.
15. Mazzucco CE, Hamatake RK, Colonno RJ, et al. Entecavir for treatment of hepatitis b virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition. Antimicrob Agents Chemother 2008;52:598-605.
16. Dalakas MC, Illa I, Pezeshkpour GH, et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990;322:1098-105.
17. Bourgeois JM, Tarnopolsky MA. Pathology of skeletal muscle in mitochondrial disorders. Mitochondrion 2004;4:441-52.
18. Chan DC. Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 2006;22:79-99.
19. Okamoto K, Shaw JM. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Annu Rev Genet 2005;39:503-36.
20. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012;337:1062-5.
21. Schapira AH. Mitochondrial diseases. Lancet 2012;379:1825-34.
22. Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev 2008;22:1577-90.
23. Nakada K, Sato A, Hayashi J. Mitochondrial functional complementation in mitochondrial DNA-based diseases. Int J Biochem Cell Biol 2009;41:1907-13.
24. Sato A, Nakada K, Hayashi J. Mitochondrial complementation preventing respiratory dysfunction caused by mutant mtdna. Biofactors 2009;35:130-7.
25. Ono T, Isobe K, Nakada K, et al. Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat Genet 2001;28:272-5.